Top Canadian Cannabis Stocks for Mid-February 2024
The Canadian cannabis sector remains a hotbed of activity, drawing attention from investors globally. With legalization trends expanding, Canadian marijuana stocks are at the forefront. This week, several companies stand out due to their market movements and potential growth opportunities. Investors are keenly watching these stocks. They’re looking for signs of strong financial health and strategic positioning. Overall, the global cannabis industry’s expansion plays a crucial role in this interest.
Statistics highlight the global cannabis market’s rapid growth. It’s expected to reach significant values in the coming years. This growth is fueled by increasing legalization and acceptance of cannabis for medical and recreational use. For investors, this presents a lucrative opportunity. However, navigating this volatile market requires skill. Using technical analysis and proper risk management is essential. These tools help investors identify trends and make informed decisions. They also minimize potential losses in this high-risk, high-reward sector.
[Read More] Cannabis Investing 2024: 3 Top Marijuana Stocks To Watch
Canadian Cannabis Companies Poised for Growth
- Canopy Growth Corporation (NASDAQ: CGC)
- Cronos Group Inc. (NASDAQ: CRON)
- SNDL Inc. (NASDAQ: SNDL)
Canopy Growth Corporation
With its headquarters located in Smiths Falls, Canada, Canopy Growth Corporation is a leading light in the international cannabis sector. Since its founding in 2013, it has developed into one of the biggest cannabis businesses globally. Canopy Growth is a company that produces, sells, and distributes cannabis products for both recreational and medical purposes. Their product line consists of topicals, soft gel capsules, infused drinks, dried flowers, and oil.
In April 2023, Canopy Growth increased the number of retail locations it operates across Canada under a variety of labels, including Tokyo Smoke and Tweed. They are widely distributed in states with progressive cannabis laws, such as British Columbia, Alberta, and Ontario. Through collaborations and acquisitions, the company’s foreign endeavors are expanding into the United States, especially in places where cannabis is legal. It could be necessary to update certain store counts and states with the highest presence for the current year.
Financial Highlights
The financial results for Canopy Growth in Q3 of FY2024, show notable enhancements and strategic advances. The company’s combined gross margin was 36%, with the Canada cannabis gross margin rising significantly to 28% from 11% the year before. cheaper charges for excess and obsolete inventory, cheaper operational costs as a result of cost-cutting measures, and the usage of more economically priced commodities are all credited with this growth. Furthermore, although its total net revenue dropped by 7% to $79MM, Canopy Growth’s consolidated net revenue increased by 6% year over year when the impact of selling its national retail business in Canada was taken out. The Rest-of-World cannabis segment experienced an 81% revenue increase, fueled by strong growth in Australia, a resurgence in Europe due to new products and improved sales execution, and overcoming previous negative impacts in non-core markets.
The company also reported significant milestones in product sales and financial restructuring. Storz & Bickel’s net revenue surged by 54% sequentially, propelled by robust sales of the new VENTY portable vaporizer and a highly successful Black Friday event, marking the brand’s best sales in 20 years. Free cash flow from continuing operations showed a 57% year-over-year improvement, with a cash and short-term investments balance of $186MM and a $69MM reduction in overall debt during Q3 FY2024. CEO David Klein emphasized Canopy Growth’s focused growth across all business units and its unique position to offer exposure to the U.S. cannabis market through the Canopy USA strategy. CFO Judy Hong highlighted the company’s improved profitability, reduced cash burn, and the expectation of achieving positive Adjusted EBITDA in each business unit by the fiscal year-end.
[Read More] Leading Canadian Cannabis Stock Powers Through with Strong Weekly Momentum
Cronos Group Inc.
Cronos Group Inc. is a globally recognized cannabis corporation. This Canadian business operates in the cannabis industry. Their primary objectives are to produce and sell cannabis-related goods. Cannabis for both medical and recreational use is covered under this. The Cronos Group’s innovative approach has significantly impacted the market. The company has a strong global reputation, with a particular emphasis on North America.
In April 2023, there were several states in the United States where Cronos Group had a retail presence. Because they have a lot of stores, they are well-represented in places where cannabis is legal. The company has placed itself strategically in cannabis-heavy markets in the United States. This covers both the medical and recreational markets. Cronos Group’s expansion into these states is a testament to its commitment to accessibility. Their goal is to effectively establish connections with a wide range of clients.
Third Quarter 2023
Cronos Group Inc. recorded a net revenue of $24.8 million for the third quarter of 2023. There was a $4.4 million increase from this period in 2022 to the current one. The rise in the adult-use market for cannabis flowers and extracts in Canada was one of the primary reasons for the hike. Nevertheless, there were problems with this upward trend. Israel’s decreased flower sales and Canada’s higher excise tax payments were two noteworthy issues. Geopolitical upheaval and competitive pricing pressure were the causes of these problems. The financial outcomes were also adversely affected by changes in the exchange rates of the US dollar, Canadian dollar, and New Israeli Shekel.
The Cronos Group’s gross profit climbed by $0.8 million to $4.0 million in Q3 2023 from Q3 2022. Reduced costs for biomass and increased sales in the Canadian market were the main drivers of this expansion. But a write-down of inventories and a drop in sales in Israel offset the profit. A $0.7 million write-down was incurred as a result of the “Cronos Fermentation” factory in Winnipeg, Manitoba, closing. A 19% gross margin would have resulted from this write-down. Furthermore, adjusted EBITDA increased by $3.3 million from the prior year to $(15.2) million. The primary element that led to this improvement was a decrease in general and administrative costs.
Guidance and Outlook
The Cronos Group reiterates its goal of cutting operational expenses by $20–$25 million by 2023. An additional $10–$15 million in savings are projected for 2024. Sales, marketing, administration, and research & development are expected to be involved in these cutbacks. The business anticipates a net cash change reduction of less than $5 to $10 million in the fourth quarter of 2023. However, they expect a positive net cash change in 2024. Stable interest rates and little impact from the Israeli-Hamas war are the foundations of this prediction. The company is closely monitoring developments in Israel. It is still unclear how it will affect the company’s employees, operations, and finances.
[Read More] The Best Marijuana Stocks To Start The Week
Sundial Growers Inc.
Located in Calgary, Alberta, Canada, Sundial Growers Inc. is a well-known participant in the cannabis market. When Sundial was first established in 2006, its main goal was to grow and distribute cannabis meant for adult consumption. Pre-rolls, vapes, and dried flower are all part of their product lineup. They are renowned for their dedication to producing high-quality, safe, and dependable products.
In Canada, Sundial runs a sizable number of retail locations, most of which are in Alberta, British Columbia, and Ontario. Marijuana products are heavily marketed in these areas. When I last gave you an update in April 2023, Sundial was unavailable in all foreign markets, including the US. It seems that their growth plan is centered on growing and merging their Canadian businesses. In Canada’s cannabis industry, Sundial has established a strong reputation thanks to its emphasis on quality and client satisfaction.
Third Quarter 2023 Financial And Operational Highlights
In the third quarter of 2023, SNDL reported significant financial and operational progress, including a net cash flow from operating activities of $27.5 million, up from $8.6 million in the previous year, and a positive free cash flow of $16.5 million, a stark contrast to the negative $67.1 million in the third quarter of 2022. The company’s unrestricted cash increased to $202.0 million, marking an 8.9% sequential rise due to effective cash management and operational efficiencies, particularly in working capital.
Net revenue grew by 3.1% year-over-year to $237.6 million, with each segment contributing to this growth: Liquor Retail remained stable at $151.8 million, Cannabis Retail increased by 14.1% to $75.5 million, and Cannabis Operations surged by 77.4% to $21.0 million. However, the gross margin slightly decreased by 3.4% due to non-cash inventory impairments, and the net loss improved by 77.9% to $21.8 million, primarily due to lesser asset impairments than the previous year.
SNDL’s CEO, Zach George, emphasized the company’s dedication to achieving operational and financial excellence, with a focus on profitability, growth, and efficiency across all segments. Significant strides have been made in the Liquor Retail segment with the launch of an e-commerce platform and a data licensing program to enhance profit margins. The Cannabis Retail segment saw a 14.1% increase in net revenue, and the Cannabis Operations segment reported a 77.4% increase in net revenue, despite a negative gross margin. SNDL’s strategic investments and the restructuring of key U.S. credit exposures comply with U.S. laws. With an industry-leading balance sheet and improved operations, SNDL aims to build a sustainable business model that will generate strong free cash flow and create long-term shareholder value.
Spotlight on Canadian Cannabis Leaders This February
As we conclude our analysis of top Canadian cannabis stocks to watch this week, the emphasis on technical analysis becomes paramount. In addition, investors should scrutinize chart patterns, volume analysis, and moving averages to gauge market sentiment. These indicators can highlight potential entry and exit points, offering a strategic edge. Overall, It’s crucial to identify stocks showing strength in trading momentum or those nearing key support levels. Such technical diligence can uncover opportunities amidst the sector’s volatility.
It is impossible to overestimate the importance of risk management in this highly volatile industry. Diversifying holdings across different cannabis companies can mitigate risks associated with any single stock. Setting stop-loss orders ensures investors limit potential losses, safeguarding their portfolios against unforeseen market downturns. Additionally, staying informed about regulatory changes and market trends will aid in making informed decisions. Also, by combining technical analysis with stringent risk management practices, investors can navigate the complexities of the Canadian cannabis market with greater confidence and potential for returns.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
